Detalles de la búsqueda
1.
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Br J Haematol
; 185(3): 450-467, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30729512
2.
High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 15(8): 874-85, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24948586
3.
Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.
Blood
; 119(23): 5374-83, 2012 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22498739
4.
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
Blood Cancer J
; 13(1): 38, 2023 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36922489
5.
Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.
Lancet Oncol
; 12(8): 743-52, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21771568
6.
Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study.
Bone Marrow Transplant
; 57(10): 1507-1513, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768571
7.
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.
Lancet
; 376(9757): 1989-99, 2010 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21131037
8.
Assessment of bone marrow response in Waldenström's macroglobulinemia.
Clin Lymphoma Myeloma
; 9(1): 53-5, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19362973
9.
Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial.
Bone Marrow Transplant
; 59(3): 431-434, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38195983
10.
The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial.
Trials
; 19(1): 169, 2018 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29514706
11.
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Lancet Haematol
; 3(7): e340-51, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27374467
12.
Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Oncogene
; 22(7): 1103-13, 2003 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-12592397
13.
Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study.
Leuk Lymphoma
; 53(2): 282-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21846185
14.
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma.
Blood
; 102(7): 2345-50, 2003 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12791655
15.
Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.
Blood
; 100(9): 3095-100, 2002 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12384404
16.
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.
Blood
; 102(13): 4504-11, 2003 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12947006
Resultados
1 -
16
de 16
1
Próxima >
>>